Is mitotic rate still useful in the management of patients with thin melanoma?

A Tejera-VaquerizoG Pérez-CabelloL Marínez-LeboransE GallegoV Oliver-MartínezP Martín-CuevasS Arias-SantiagoJ Aneiros-FernándezE Herrera-AcostaV TravesE Herrera-CeballosEduardo Nagore

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2017)

Sentinel lymph node metastasis was less common in patients with T1b melanoma who had a mitotic rate of ≤1 mitoses/mm2 . Performance of SLN biopsy should be carefully considered in this subgroup of patients, particularly considering the good prognosis.

Keyphrases

sentinel lymph node
end stage renal disease
early stage
lymph node
newly diagnosed
ejection fraction
chronic kidney disease
neoadjuvant chemotherapy
peritoneal dialysis
randomized controlled trial
clinical trial
patient reported outcomes